These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
635 related articles for article (PubMed ID: 35996248)
1. Identification of Hub Genes Associated with Tumor-Infiltrating Immune Cells and ECM Dynamics as the Potential Therapeutic Targets in Gastric Cancer through an Integrated Bioinformatic Analysis and Machine Learning Methods. Liu J; Cheng Z Comb Chem High Throughput Screen; 2023; 26(4):653-667. PubMed ID: 35996248 [TBL] [Abstract][Full Text] [Related]
2. Identification of Hub Genes and Pathways in Gastric Adenocarcinoma Based on Bioinformatics Analysis. Qiu J; Sun M; Wang Y; Chen B Med Sci Monit; 2020 Feb; 26():e920261. PubMed ID: 32058995 [TBL] [Abstract][Full Text] [Related]
3. Integrated bioinformatics analysis for differentially expressed genes and signaling pathways identification in gastric cancer. Yang C; Gong A Int J Med Sci; 2021; 18(3):792-800. PubMed ID: 33437215 [No Abstract] [Full Text] [Related]
4. Integrated bioinformatics analysis for the screening of hub genes and therapeutic drugs in ovarian cancer. Yang D; He Y; Wu B; Deng Y; Wang N; Li M; Liu Y J Ovarian Res; 2020 Jan; 13(1):10. PubMed ID: 31987036 [TBL] [Abstract][Full Text] [Related]
5. Identification of significant genes associated with prognosis of gastric cancer by bioinformatics analysis. Wang S; Tao S; Liu Y; Shi Y; Liu M J Egypt Natl Canc Inst; 2022 Dec; 34(1):55. PubMed ID: 36567425 [TBL] [Abstract][Full Text] [Related]
6. FN1, SPARC, and SERPINE1 are highly expressed and significantly related to a poor prognosis of gastric adenocarcinoma revealed by microarray and bioinformatics. Li L; Zhu Z; Zhao Y; Zhang Q; Wu X; Miao B; Cao J; Fei S Sci Rep; 2019 May; 9(1):7827. PubMed ID: 31127138 [TBL] [Abstract][Full Text] [Related]
7. Identification of Potential Biomarkers Associated with Prognosis in Gastric Cancer via Bioinformatics Analysis. Li D; Yin Y; He M; Wang J Med Sci Monit; 2021 Feb; 27():e929104. PubMed ID: 33582701 [TBL] [Abstract][Full Text] [Related]
8. Screening the Biomarkers and Related Medicines for Gastric Adenocarcinoma. Lin J; Xu N; An W J Coll Physicians Surg Pak; 2024 Mar; 34(3):290-295. PubMed ID: 38462863 [TBL] [Abstract][Full Text] [Related]
9. Hub genes and pathways in gastric cancer: A comparison between studies that used normal tissues adjacent to the tumour and studies that used healthy tissues as calibrator. Sadegh K; Ahmadi A IET Syst Biol; 2023 Jun; 17(3):131-141. PubMed ID: 37118990 [TBL] [Abstract][Full Text] [Related]
10. High expression of ghrelin and obestatin prepropeptide in tumor tissues predicted adverse overall survival in gastric carcinoma patients. Wu X; Wu Y; Ye B; Wu F; Wang P Medicine (Baltimore); 2020 Jun; 99(26):e20635. PubMed ID: 32590738 [TBL] [Abstract][Full Text] [Related]
11. Extracellular Matrix-Related Hubs Genes Have Adverse Effects on Gastric Adenocarcinoma Prognosis Based on Bioinformatics Analysis. Alatan H; Chen Y; Zhou J; Wang L Genes (Basel); 2021 Jul; 12(7):. PubMed ID: 34356118 [TBL] [Abstract][Full Text] [Related]
12. Comprehensive Analysis of Candidate Diagnostic and Prognostic Biomarkers Associated with Lung Adenocarcinoma. Li J; Liu X; Cui Z; Han G Med Sci Monit; 2020 Jun; 26():e922070. PubMed ID: 32578582 [TBL] [Abstract][Full Text] [Related]
13. Integrated bioinformatics analysis reveals novel key biomarkers and potential candidate small molecule drugs in gastric cancer. Wu Q; Zhang B; Wang Z; Hu X; Sun Y; Xu R; Chen X; Wang Q; Ju F; Ren S; Zhang C; Qi F; Ma Q; Xue Q; Zhou YL Pathol Res Pract; 2019 May; 215(5):1038-1048. PubMed ID: 30975489 [TBL] [Abstract][Full Text] [Related]
14. Screening and Identification of Key Biomarkers in Inflammatory Breast Cancer Through Integrated Bioinformatic Analyses. Wu J; Lv Q; Huang H; Zhu M; Meng D Genet Test Mol Biomarkers; 2020 Aug; 24(8):484-491. PubMed ID: 32598242 [No Abstract] [Full Text] [Related]
15. The Analysis of Potential Diagnostic and Therapeutic Targets for the Occurrence and Development of Gastric Cancer Based on Bioinformatics. Ding C; Zhang Q; Jiang X; Wei D; Xu S; Li Q; Wu M; Wang H Comput Math Methods Med; 2022; 2022():4321466. PubMed ID: 35756405 [TBL] [Abstract][Full Text] [Related]
16. Identification of hub genes with prognostic values in gastric cancer by bioinformatics analysis. Li T; Gao X; Han L; Yu J; Li H World J Surg Oncol; 2018 Jun; 16(1):114. PubMed ID: 29921304 [TBL] [Abstract][Full Text] [Related]
17. Screening and Survival Analysis of Hub Genes in Gastric Cancer Based on Bioinformatics. Zheng S; Yang L; Dai Y; Jiang L; Wei Y; Wen H; Xu Y J Comput Biol; 2019 Nov; 26(11):1316-1325. PubMed ID: 31233344 [No Abstract] [Full Text] [Related]
18. Identification of key genes and pathways in castrate-resistant prostate cancer by integrated bioinformatics analysis. Wu YP; Ke ZB; Lin F; Wen YA; Chen S; Li XD; Chen SH; Sun XL; Huang JB; Zheng QS; Xue XY; Wei Y; Xu N Pathol Res Pract; 2020 Oct; 216(10):153109. PubMed ID: 32853947 [TBL] [Abstract][Full Text] [Related]
19. Identification of differentially expressed mRNAs as novel predictive biomarkers for gastric cancer diagnosis and prognosis. Zhou JW; Zhang YB; Huang ZY; Yuan YP; Jin J World J Gastrointest Oncol; 2024 May; 16(5):1947-1964. PubMed ID: 38764850 [TBL] [Abstract][Full Text] [Related]
20. Screening Hub Genes as Prognostic Biomarkers of Hepatocellular Carcinoma by Bioinformatics Analysis. Zhou Z; Li Y; Hao H; Wang Y; Zhou Z; Wang Z; Chu X Cell Transplant; 2019 Dec; 28(1_suppl):76S-86S. PubMed ID: 31822116 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]